AI assistant
Sending…
PULSE BIOSCIENCES, INC. — Director's Dealing 2022
Mar 22, 2022
32093_dirs_2022-03-22_2eae829b-1b5d-4256-af91-fedf7cad0f4d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2022-02-14
Reporting Person: Danahy Kevin Patrick (Chief Commercial Officer)
More from PULSE BIOSCIENCES, INC.
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 11
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 16
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 17